InsiderTrades

Form 4 for ANIP ANI PHARMACEUTICALS INC

Accepted 2024-03-07 00:00:00 ET · period of report 2024-03-05 · accession 0001870913-24-000010 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
MI 2024-03-07 2024-03-05+ ANIP Shanmugam Muthusamy HEAD OF R, D, COO-NOVITIUM OPS, Dir S - Sale $65.77 -40.0K 842.6K -5% -$2.63M

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-03-05 S D 10,093 $65.35 872,527 I Held by Esjay LLC — — (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $64.45 to $66.58, inclusive. (F3) The reporting person holds voting and dispositive power over the shares held by Esjay LLC.
2 Common Common Stock 2024-03-06 S D 14,822 $65.47 857,705 I Held by Esjay LLC — — (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $64.84 to $66.04, inclusive. (F3) The reporting person holds voting and dispositive power over the shares held by Esjay LLC.
3 Common Common Stock 2024-03-07 S D 15,085 $66.35 842,620 I Held by Esjay LLC — — (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $65.53 to $67.00, inclusive. (F3) The reporting person holds voting and dispositive power over the shares held by Esjay LLC.